Primary mediastinal large B-cell lymphomas treated with dose-intensified CHOP alone or CHOP combined with radiotherapy.

作者: Marcel Massoud , Serge Koscielny , Simona Lapusan , Jacques Bosq , Vincent Ribrag

DOI: 10.1080/10428190802203788

关键词:

摘要: We retrospectively reviewed 105 cases of primary mediastinal large B-cell lymphoma (PMLBL). Patients were treated with dose-intensified chemotherapy according to the GELA protocols without planned radiotherapy. Radiotherapy was delivered patients a proven sensitive CHOP who could receive irradiation for localised disease. Seventy-six achieved complete remission (24%) or unconfirmed CR (49%), and 15 (14%), partial remission. intensified induction therapy had better FFP rate than even when radiotherapy restricted responders regimen (p = 0.01). In multivariate analysis overall survival, poor performance status remained associated outcome 0.02 0.02, respectively). might not be necessary in PMLBL Cru is chemotherapy. yield inferior results compared more frequent progression on therapy.

参考文章(25)
S Joos, MI Otano-Joos, S Ziegler, S Bruderlein, S du Manoir, M Bentz, P Moller, P Lichter, Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene Blood. ,vol. 87, pp. 1571- 1578 ,(1996) , 10.1182/BLOOD.V87.4.1571.BLOODJOURNAL8741571
D Kirn, P Mauch, K Shaffer, G Pinkus, M A Shipp, W D Kaplan, N Tung, C Wheeler, C J Beard, G P Canellos, Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients. Journal of Clinical Oncology. ,vol. 11, pp. 1336- 1343 ,(1993) , 10.1200/JCO.1993.11.7.1336
M Lazzarino, E Orlandi, M Paulli, E Boveri, E Morra, E Brusamolino, S Kindl, R Rosso, C Astori, M C Buonanno, Primary mediastinal B-cell lymphoma with sclerosis: an aggressive tumor with distinctive clinical and pathologic features. Journal of Clinical Oncology. ,vol. 11, pp. 2306- 2313 ,(1993) , 10.1200/JCO.1993.11.12.2306
Corinne Haioun, Eric Lepage, Christian Gisselbrecht, Gilles Salles, Bertrand Coiffier, Pauline Brice, André Bosly, Pierre Morel, Christiane Nouvel, Hervé Tilly, Pierre Lederlin, Catherine Sebban, Josette Brière, Philippe Gaulard, Félix Reyes, Survival Benefit of High-Dose Therapy in Poor-Risk Aggressive Non-Hodgkin’s Lymphoma: Final Analysis of the Prospective LNH87–2 Protocol—A Groupe d’Etude des Lymphomes de l’Adulte Study Journal of Clinical Oncology. ,vol. 18, pp. 3025- 3030 ,(2000) , 10.1200/JCO.2000.18.16.3025
M Lazzarino, E Orlandi, M Paulli, J Sträter, C Klersy, U Gianelli, L Gargantini, M T Rousset, M Gambacorta, E Marra, T Lavabre-Bertrand, U Magrini, C Manegold, C Bernasconi, P Möller, Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients. Journal of Clinical Oncology. ,vol. 15, pp. 1646- 1653 ,(1997) , 10.1200/JCO.1997.15.4.1646
Hervé Tilly, Nicolas Mounier, Pierre Lederlin, Josette Brière, Brigitte Dupriez, Catherine Sebban, André Bosly, Pierre Biron, Catherine Nouvel, Raoul Herbrecht, Dominique Bordessoule, Bertrand Coiffier, , Randomized Comparison of ACVBP and m-BACOD in the Treatment of Patients With Low-Risk Aggressive Lymphoma: The LNH87-1 Study Journal of Clinical Oncology. ,vol. 18, pp. 1309- 1315 ,(2000) , 10.1200/JCO.2000.18.6.1309
Martin Bentz, Thomas F. E. Barth, Silke Br�derlein, Daliah Bock, Michael J. Schwerer, Michael Baudis, Stefan Joos, Andreas Viardot, Alfred C. Feller, Hans-Konrad M�ller-Hermelink, Peter Lichter, Hartmut D�hner, Peter M�ller, Gain of chromosome arm 9p is characteristic of primary mediastinal B-cell lymphoma (MBL): comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line. Genes, Chromosomes and Cancer. ,vol. 30, pp. 393- 401 ,(2001) , 10.1002/1098-2264(2001)9999:9999<::AID-GCC1105>3.0.CO;2-I
D. Cazals-Hatem, E. Lepage, P. Brice, A. Ferrant, M. F. d'Agay, E. Baumelou, J. Brière, M. Blanc, P. Gaulard, P. Biron, D. Schlaifer, J. Diebold, J. Audouin, Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d'Etude des Lymphomes de l'Adulte") study. The American Journal of Surgical Pathology. ,vol. 20, pp. 877- 888 ,(1996) , 10.1097/00000478-199607000-00012
HR Cairoli, G Grillo, A Tedeschi, L Gargantini, P Marenco, E Tresoldi, L Barbarano, AM Nosari, E Morra, Efficacy of an early intensification treatment integrating chemotherapy, autologous stem cell transplantation and radiotherapy for poor risk primary mediastinal large B cell lymphoma with sclerosis. Bone Marrow Transplantation. ,vol. 29, pp. 473- 477 ,(2002) , 10.1038/SJ.BMT.1703401
Ingo Melzner, Alexandra Juliana Bucur, Silke Brüderlein, Karola Dorsch, Cornelia Hasel, Thomas F. E. Barth, Frank Leithäuser, Peter Möller, Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line Blood. ,vol. 105, pp. 2535- 2542 ,(2004) , 10.1182/BLOOD-2004-09-3701